Purpose
In the last decade several different radiotherapy treatment plan evaluation and optimization schemes have been proposed as viable approaches, aiming in dose escalation or in an increase of healthy tissue sparing. In particular it has been argued that dose-mass plan evaluation and treatment plan optimization might be viable alternatives to the standard of care, which is realized through dose-volume evaluation and optimization. The purpose of this investigation is to apply dose-mass optimization to a cohort of lung cancer patients and compare the achievable healthy tissue sparing to the one achievable through dose-volume optimization.
Materials and Methods
Fourteen non-small cell lung cancer (NSCLC) patient plans were studied retrospectively. The range of tumor motion was below 0.5 cm and motion management in the treatment planning process was not considered. For each case dose-volume (DV) based and dose-mass (DM) based optimization was carried out. Nine-field step-and-shoot IMRT was used, where all of the optimization parameters were kept the same between DV and DM optimizations. Commonly used dosimetric indices (DIs) such as dose to 1% the spinal cord volume, dose to 50% of the esophageal volume, doses to 20% and 30% of healthy lung volumes, were used for cross-comparison. Similarly, mass-based indices (MIs), such as doses to 20% and 30% of healthy lung masses, 1% of spinal cord mass, 33% of heart mass, were also tallied. Statistical equivalence tests were performed to quantify the findings on the entire patient cohort.
Results
Both DV and DM plans for each case were normalized such that 95% of the planning target volume received the prescribed dose. DM optimization resulted in more organs at risk (OAR) sparing than DV optimization. The average sparing of cord, heart, and esophagus is 23%, 4%, and 6%, respectively. For the majority of the DIs, DM optimization resulted in lower lung doses. On average the doses to 20% and 30% of healthy lung were lower by about 3% and 4%, while lungs volumes receiving 2000 cGy and 3000 cGy are lower by 3% and 2%, respectively. The behavior of MIs was very similar. The statistical analyses of the results again indicated better healthy anatomical structures sparing with DM optimization.
Conclusions
The presented findings indicate that dose-mass based optimization results in statistically significant OAR sparing as compared to dose-volume based optimization for NSCLC. However, the sparing is case dependent and it is not observed for all tallied dosimetric endpoints.